Background Glucosamine and chondroitin sulfate are used to treat osteoarthritis. The
multicenter, double-blind, placebo- and celecoxib-controlled Glucosamine/chondroitin Arthritis …

Tuberculosis (TB), caused by infection with Mycobacterium tuberculosis, is a major cause of
morbidity and mortality worldwide. Efforts to control it are hampered by difficulties with …

Objective. To determine whether sulfasalazine (SSZ) at a dosage of 2,000 mg/day is effective
for the treatment of active psoriatic arthritis (PsA) resistant to nonsteroidal antiinflammatory …

We reviewed the long‐term natural history of 21 adult‐onset Still's disease patients. Patient
subsets were identified according to clinical course patterns. These included monocyclic …

Background: Disease-modifying antirheumatic drugs may confer greater benefits when
combined with the antimetabolite methotrexate. Objective: To evaluate the efficacy and safety of …

Objective: To assess the efficacy and safety of 100 mg daily anakinra (Kineret), a recombinant
form of the naturally occurring interleukin 1 receptor antagonist, plus methotrexate (MTX) …

Objective. To determine whether sulfasalazine (SSZ) at a dosage of 2,000 mg/day is
effective for the treatment of active ankylosing spondylitis (AS) that is not controlled with …

Objective. Interleukin‐10 (IL‐10) has been shown to exert both antiinflammatory and
immunostimulatory effects in vivo and in vitro. We therefore sought to examine the role of this …

Studies on the role of the RNA receptor TLR8 in inflammation have been limited by its different
function in human versus rodents. We have generated multiple lines of transgenic mice …

Cytofluorometric analysis was performed to characterize the surface phenotype and
activation status of freshly isolated synovial tissue lymphocytes (STL) and peripheral blood …